ESTHER
CONDE GALLEGO
Profesora asociada de Ciencias de la Salud
![Foto de ESTHER](/img/nophoto.png)
![Foto de Hospital Universitario La Paz](/img/noimage_org.png)
Hospital Universitario La Paz
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario La Paz (13)
2024
-
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach
Archives of pathology & laboratory medicine, Vol. 148, Núm. 3, pp. 318-326
-
RET Fusion Testing in Patients With NSCLC: The RETING Study
JTO Clinical and Research Reports, Vol. 5, Núm. 4
-
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer
Clinical Cancer Research, Vol. 30, Núm. 14, pp. 3036-3049
-
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium
Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 352-362
2021
-
Pan-TRK immunohistochemistry an example-based practical approach to efficiently identify patients with NTRK fusion cancer
Archives of Pathology and Laboratory Medicine, Vol. 145, Núm. 8, pp. 1031-1040
-
Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges
Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025
2020
-
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens
Cancer Cytopathology, Vol. 128, Núm. 12, pp. 928-938
-
Immunotherapy moves to the early-stage setting in non-small cell lung cancer: Emerging evidence and the role of biomarkers
Cancers, Vol. 12, Núm. 11, pp. 1-21
-
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 167-181
-
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 22, Núm. 7, pp. 989-1003
2019
-
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132
2014
2013
-
IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer
Oncogene, Vol. 32, Núm. 10, pp. 1274-1283